ApoD’s involvement in Alzheimer disease has been known for almost three decades, when it was first observed that its level in the cerebrospinal fluid and hippocampus of Alzheimer’s patient was more than 3× higher than normal [86,87,88]. The gene discussed is APOD; the disease is early-onset autosomal dominant Alzheimer disease.